Clinical Trial Update: Remediation of Schizophrenia Sensory Gating Deficit With Aripiprazole [NA]

View source ↗

Summary

The document describes a clinical trial assessing whether aripiprazole can remediate sensory gating deficits in schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)

Snippet

Sponsor: New Mexico VA Healthcare System | Conditions: Schizophrenia, Sensory Gating | NA | Status: UNKNOWN